A clinical and genetic study in a large cohort of patients with spinocerebellar ataxia type 6
- PMID: 15362569
- DOI: 10.1007/s10038-004-0142-7
A clinical and genetic study in a large cohort of patients with spinocerebellar ataxia type 6
Abstract
In order to clarify the clinical and genetic features of SCA6, we retrospectively analyzed 140 patients. We observed an inverse correlation between the age of onset and the length of the expanded allele, and also between the age of onset and the sum of CAG repeats in the normal and the expanded alleles. The ages of onset of four homozygous patients correlated better with the sum of CAG repeats in both alleles rather than with the expanded allele calculated from heterozygous SCA6 subjects. Clinically, unsteadiness of gait was the main initial symptom, followed by vertigo and oscillopsia, and cerebellar signs were detected in nearly 100% of the patients. In contrast, extracerebellar signs were relatively mild and infrequent. The results of neuro-otological examination performed in 22 patients suggested the purely cerebellar abnormalities of ocular movements in nature. There was a close relationship between downbeat positioning nystagmus (DPN) and positioning vertigo, which became more common in the later stage. We conclude that total number of CAG repeat-units in both alleles is a good parameter for assessment of age of onset in SCA6 including homozygous patients. In addition, clinical and neuro-otological examinations suggested that SCA6 is a disease with predominantly cerebellar dysfunction.
Similar articles
-
Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.Arch Neurol. 2000 Apr;57(4):540-4. doi: 10.1001/archneur.57.4.540. Arch Neurol. 2000. PMID: 10768629
-
Gene dosage effect in spinocerebellar ataxia type 6 homozygotes: A clinical and neuropathological study.J Neurol Sci. 2017 Feb 15;373:321-328. doi: 10.1016/j.jns.2016.12.051. Epub 2016 Dec 27. J Neurol Sci. 2017. PMID: 28131213
-
Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17.Arch Neurol. 2004 Feb;61(2):209-12. doi: 10.1001/archneur.61.2.209. Arch Neurol. 2004. PMID: 14967767
-
Spinocerebellar ataxia type 6 and episodic ataxia type 2: differences and similarities between two allelic disorders.Cytogenet Genome Res. 2003;100(1-4):147-53. doi: 10.1159/000072849. Cytogenet Genome Res. 2003. PMID: 14526175 Review.
-
[Clinical, neuropathological and genetic characteristics of spinocerebellar ataxia type 6 (SCA6)].Nihon Rinsho. 1999 Apr;57(4):880-5. Nihon Rinsho. 1999. PMID: 10222783 Review. Japanese.
Cited by
-
Spinocerebellar ataxia 27B: A novel, frequent and potentially treatable ataxia.Clin Transl Med. 2024 Jan;14(1):e1504. doi: 10.1002/ctm2.1504. Clin Transl Med. 2024. PMID: 38279833 Free PMC article. Review.
-
Loss of MyD88 alters neuroinflammatory response and attenuates early Purkinje cell loss in a spinocerebellar ataxia type 6 mouse model.Hum Mol Genet. 2015 Sep 1;24(17):4780-91. doi: 10.1093/hmg/ddv202. Epub 2015 Jun 1. Hum Mol Genet. 2015. PMID: 26034136 Free PMC article.
-
Dysphagia Affecting Quality of Life in Cerebellar Ataxia-a Large Survey.Cerebellum. 2020 Jun;19(3):437-445. doi: 10.1007/s12311-020-01122-w. Cerebellum. 2020. PMID: 32170655 Free PMC article.
-
Visual Suppression is Impaired in Spinocerebellar Ataxia Type 6 but Preserved in Benign Paroxysmal Positional Vertigo.Diagnostics (Basel). 2012 Oct 11;2(4):52-6. doi: 10.3390/diagnostics2040052. Diagnostics (Basel). 2012. PMID: 26859398 Free PMC article.
-
Sensorimotor Cough Dysfunction in Cerebellar Ataxias.Cerebellum. 2024 Aug;23(4):1338-1347. doi: 10.1007/s12311-023-01635-0. Epub 2023 Nov 30. Cerebellum. 2024. PMID: 38032397 Free PMC article.